Read More Pharma Industry News How Brazilian drugmaker Blau Farmacêutica quietly built a pembrolizumab biosimilar that could challenge Big Pharma Blau Farmacêutica completes Brazil’s first full pembrolizumab biosimilar. Find out how this could reshape global immunotherapy access and biosimilar strategy. byVenkateshJanuary 24, 2026